Article
A review of current anti-HCV treatment regimens and possible future strategies.
Expert opinion on pharmacotherapy - 1 Feb 2009
Neukam Karin, Macías Juan, Mira José A, Pineda Juan A
Abstract excerpt
BACKGROUND: Hepatitis C virus (HCV) infection remains a serious health problem worldwide. The current standard treatment of HCV infection is pegylated interferon-alpha plus ribavirin, but this is clearly not sufficiently effective and tolerable. OBJECTIVE: To review current HCV treatment strategies and future options. METHODS: Review of major clinical trials or observational studies when no trial is available....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.